These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 16459490)

  • 21. Drug treatment of poststroke aphasia.
    Bakheit AM
    Expert Rev Neurother; 2004 Mar; 4(2):211-7. PubMed ID: 15853562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The consequences of closed traumatic brain injury and piracetam efficacy in their treatment in adolescents].
    Zavadenko NN; Guzilova LS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):43-8. PubMed ID: 18427539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study.
    Enderby P; Broeckx J; Hospers W; Schildermans F; Deberdt W
    Clin Neuropharmacol; 1994 Aug; 17(4):320-31. PubMed ID: 9316679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects.
    Moriau M; Crasborn L; Lavenne-Pardonge E; von Frenckell R; Col-Debeys C
    Arzneimittelforschung; 1993 Feb; 43(2):110-8. PubMed ID: 8457235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differences in the effects of piracetam and fenazepam in emotional stress caused by the spatial reversal of a habit].
    Inozemtsev AN; Voronina TA; Pragina LL; Krutikova IA; Tushmalova NA
    Eksp Klin Farmakol; 1996; 59(6):3-5. PubMed ID: 9181869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.
    Kessler J; Thiel A; Karbe H; Heiss WD
    Stroke; 2000 Sep; 31(9):2112-6. PubMed ID: 10978039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Scavenger effect of various cerebrovascular drugs].
    Horváth B; Márton Z; Halmosi R; Alexy T; Szapáry L; Vékási J; Bíró Z; Habon T; Késmárky G; Tóth K
    Orv Hetil; 2002 Jan; 143(1):13-7. PubMed ID: 11816373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of amiridine on rat learning in a radial maze].
    Burov IuV; Borisova AO; Robakidze TN
    Biull Eksp Biol Med; 1996 May; 121(5):526-7. PubMed ID: 8744128
    [No Abstract]   [Full Text] [Related]  

  • 29. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.
    Malykh AG; Sadaie MR
    Drugs; 2010 Feb; 70(3):287-312. PubMed ID: 20166767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nootropics: preclinical results in the light of clinical effects; comparison with tacrine.
    Mondadori C
    Crit Rev Neurobiol; 1996; 10(3-4):357-70. PubMed ID: 8978986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
    Kyomen HH; Whitfield TH; Baldessarini RJ
    J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
    [No Abstract]   [Full Text] [Related]  

  • 32. [A neuroprotective effect of the herbal drug neurofit in alcoholic intoxication].
    Dashinamzhilov ZhB; Lonshakova KS; Ubasheev IO; Nikolaev SM; Gulevich AA
    Patol Fiziol Eksp Ter; 2007; (4):27-9. PubMed ID: 18154085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Piracetam, an AMPAkine drug, facilitates memory consolidation in the day-old chick.
    Samartgis JR; Schachte L; Hazi A; Crowe SF
    Pharmacol Biochem Behav; 2012 Dec; 103(2):353-8. PubMed ID: 22940587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of nebracetam on content of high-energy phosphates and morphometry of rat astrocytes in vitro. Comparison with piracetam.
    Gabryel B; Pudełko A; Trzeciak HI; Cieślik P
    Acta Pol Pharm; 2000; 57(4):289-98. PubMed ID: 11126618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of piracetam on the behavior of Nauphoeta cinerea cockroaches in an open field].
    Inozemtsev AN; Tselkova NV; Bernuĭ LKh; Zhuzhikov DP; Tushmalova NA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(2):260-6. PubMed ID: 9644806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of the nootropic agents piracetam and GBS-111 on potential-dependent ion channels in the neuronal membrane].
    Solntseva EI; Bukanova IuV; Ostrovskaia RU; Gudasheva TA; Voronina TA; Skrebitskiĭ VG
    Biull Eksp Biol Med; 1996 Feb; 121(2):151-5. PubMed ID: 9026117
    [No Abstract]   [Full Text] [Related]  

  • 37. [Novel endogenous dipeptide cycloprolyl-glycine is similar to pyracetam in selectivity of their mnemotropic effect].
    Gudasheva TA; Ostrovskaia RU; Trofimov SS; Voronina TA; Skoldinov AP; Seredenin SB
    Biull Eksp Biol Med; 1999 Oct; 128(10):411-3. PubMed ID: 10599497
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of piracetam and oxiracetam on the content of high-energy phosphates and morphometry of astrocytes in vitro.
    Gabryel B; Trzeciak HI; Pudełko A; Cieślik P
    Pol J Pharmacol; 1999; 51(6):485-95. PubMed ID: 10817526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between psychological and pharmacological treatment in cognitive impairment.
    Deberdt W
    Life Sci; 1994; 55(25-26):2057-66. PubMed ID: 7997065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of neurotropic and stress-protective properties of piracetam and the derivative pyrido]1,2-a]pyrimidine].
    Kozlovskaia MM; Inozemtsev AN; Nikitin SV; Gochmuradov AG; Iakushev RA; Chabak-Gorbach R
    Biull Eksp Biol Med; 1995 Mar; 119(3):299-301. PubMed ID: 7795202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.